| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Isoforms Originated from the P1 Promoter Are Expressed in Human Pancreatic ß-Cells and Exhibit Stronger Transcriptional Potentials than P2 Promoter-Driven Isoforms
Institut National de la Santé et de la Recherche Médicale Unit 459 (J.E., E.M., P.F., B.L.); and Diabetes Cell Therapy Unit, ERIM 106 Institut National de la Santé et de la Recherche Médicale (T.B., B.L., F.P., J.K.-C., B.V.), Faculté H. Warembourg, Lille F 59045, France
Address all correspondence and requests for reprints to: B. Laine, Institut National de la Santé et de la Recherche Médicale Unit 459, Laboratoire de Biologie Cellulaire, Université H. Warembourg, 1 Place de Verdun, F 59045 Lille, France. E-mail: blaine{at}lille.inserm.fr.
The nuclear receptor hepatocyte nuclear factor (HNF) 4
is involved in a transcriptional network and plays an important role in pancreatic ß-cells. Mutations in the HNF4
gene are correlated with maturity-onset diabetes of the young 1. HNF4
isoforms result from both alternative splicing and alternate usage of promoters P1 and P2. It has recently been reported that HNF4
transcription is driven almost exclusively by the P2 promoter in pancreatic islets. We observed that transcripts from both P1 and P2 promoters were expressed in human pancreatic ß-cells and in the pancreatic ß-cell lines RIN m5F and HIT-T15. Expression of HNF4
proteins originating from the P1 promoter was confirmed by immunodetection. Due to the presence of the activation function module AF-1, HNF4
isoforms originating from the P1 promoter exhibit stronger transcriptional activities and recruit coactivators more efficiently than isoforms driven by the P2 promoter. Conversely, activities of isoforms produced by both promoters were similarly repressed by the corepressor small heterodimer partner. These behaviors were observed on the promoter of HNF1
that is required for ß-cell function. Our results highlight that expression of P1 promoter-driven isoforms is important in the control of pancreatic ß-cell function.
This article has been cited by other articles:
![]() |
L. W. Harries, J. M. Locke, B. Shields, N. A. Hanley, K. P. Hanley, A. Steele, P. R. Njolstad, S. Ellard, and A. T. Hattersley The Diabetic Phenotype in HNF4A Mutation Carriers Is Moderated By the Expression of HNF4A Isoforms From the P1 Promoter During Fetal Development Diabetes, June 1, 2008; 57(6): 1745 - 1752. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gates Goodyer, Z. Rhani, and H. Zheng Expression of the Hepatic Specific V1 Messenger Ribonucleic Acid of the Human Growth Hormone Receptor Gene Is Regulated by Hepatic Nuclear Factor (HNF)-4{alpha}2 and HNF-4{alpha}8 Mol. Endocrinol., February 1, 2008; 22(2): 485 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Leng, S. Lu, Y. Yao, Z. Kan, G. S. Morris, B. R. Stair, M. A. Cherny, and D. D. Black Hepatocyte nuclear factor-4 mediates apolipoprotein A-IV transcriptional regulation by fatty acid in newborn swine enterocytes Am J Physiol Gastrointest Liver Physiol, August 1, 2007; 293(2): G475 - G483. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Benoit, A. Cooney, V. Giguere, H. Ingraham, M. Lazar, G. Muscat, T. Perlmann, J.-P. Renaud, J. Schwabe, F. Sladek, et al. International Union of Pharmacology. LXVI. Orphan Nuclear Receptors Pharmacol. Rev., December 1, 2006; 58(4): 798 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Yeom, G. H. Kim, C. H. Kim, H. D. Jung, S.-Y. Kim, J.-Y. Park, Y. K. Pak, D.-K. Rhee, S.-Q. Kuang, J. Xu, et al. Regulation of Insulin Secretion and {beta}-Cell Mass by Activating Signal Cointegrator 2 Mol. Cell. Biol., June 15, 2006; 26(12): 4553 - 4563. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hara, M. Horikoshi, H. Kitazato, C. Ito, M. Noda, J. Ohashi, P. Froguel, K. Tokunaga, K. Tobe, R. Nagai, et al. Hepatocyte Nuclear Factor-4{alpha} P2 Promoter Haplotypes Are Associated With Type 2 Diabetes in the Japanese Population. Diabetes, May 1, 2006; 55(5): 1260 - 1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Bagwell, J. L. Bento, J. C. Mychaleckyj, B. I. Freedman, C. D. Langefeld, and D. W. Bowden Genetic Analysis of HNF4A Polymorphisms in Caucasian-American Type 2 Diabetes Diabetes, April 1, 2005; 54(4): 1185 - 1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Damcott, N. Hoppman, S. H. Ott, L. J. Reinhart, J. Wang, T. I. Pollin, J. R. O'Connell, B. D. Mitchell, and A. R. Shuldiner Polymorphisms in Both Promoters of Hepatocyte Nuclear Factor 4-{alpha} Are Associated With Type 2 Diabetes in the Amish Diabetes, December 1, 2004; 53(12): 3337 - 3341. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Thomas, S. Senkel, S. Erdmann, T. Arndt, G. Turan, L. Klein-Hitpass, and G. U. Ryffel Pattern of genes influenced by conditional expression of the transcription factors HNF6, HNF4{alpha} and HNF1{beta} in a pancreatic {beta}-cell line Nucleic Acids Res., November 1, 2004; 32(19): e150 - e150. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Briancon, A. Bailly, F. Clotman, P. Jacquemin, F. P. Lemaigre, and M. C. Weiss Expression of the {alpha}7 Isoform of Hepatocyte Nuclear Factor (HNF) 4 Is Activated by HNF6/OC-2 and HNF1 and Repressed by HNF4{alpha}1 in the Liver J. Biol. Chem., August 6, 2004; 279(32): 33398 - 33408. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Eeckhoute, P. Formstecher, and B. Laine Hepatocyte Nuclear Factor 4{alpha} enhances the Hepatocyte Nuclear Factor 1{alpha}-mediated activation of transcription Nucleic Acids Res., May 11, 2004; 32(8): 2586 - 2593. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Love-Gregory, J. Wasson, J. Ma, C. H. Jin, B. Glaser, B. K. Suarez, and M. A. Permutt A Common Polymorphism in the Upstream Promoter Region of the Hepatocyte Nuclear Factor-4{alpha} Gene on Chromosome 20q Is Associated With Type 2 Diabetes and Appears to Contribute to the Evidence for Linkage in an Ashkenazi Jewish Population Diabetes, April 1, 2004; 53(4): 1134 - 1140. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Silander, K. L. Mohlke, L. J. Scott, E. C. Peck, P. Hollstein, A. D. Skol, A. U. Jackson, P. Deloukas, S. Hunt, G. Stavrides, et al. Genetic Variation Near the Hepatocyte Nuclear Factor-4{alpha} Gene Predicts Susceptibility to Type 2 Diabetes Diabetes, April 1, 2004; 53(4): 1141 - 1149. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |